Osimertinib (Targeted Therapy), Third-generation EGFR-TKI, Effective in NSCLC with EGFR Ex19Del or EGFR L858R mutations, Treats central nervous system metastases,
Sale!
Lucius
Replica Osimertinib Advanced EGFR-TKI for NSCLC
Original price was: $735.00.$576.00Current price is: $576.00.
Osimertinib (Targeted Therapy), Third-generation EGFR-TKI, Effective in NSCLC with EGFR Ex19Del or EGFR L858R mutations, Treats central nervous system metastases,